Literature DB >> 31941586

Propensity score-matched analysis of clinical outcome after enucleation versus regular pancreatectomy in patients with small non-functional pancreatic neuroendocrine tumors.

Mao Weilin1, Han Xu1, Lv Yang1, Chen Wenqi1, Wang Huanyu1, Zhou Wentao1, Jin Dayong1, Wu Wenchuan1, Wang Dansong1, Kuang Tiantao1, Zhang Lei1, Lou Wenhui2, Xu Xuefeng3.   

Abstract

OBJECTIVES: The effectiveness of enucleation in treatment for low-grade (G1, G2) small (≤2 cm) non-functional pancreatic neuroendocrine tumors (sNF-pNETs) remains controversial. This study investigated short- and long-term outcome of enucleation comparing with regular pancreatectomy in patients with sNF-pNETs.
METHODS: The clinical data of patients with sNF-pNETs who underwent surgery in our hospital from January 2000 to December 2017 were retrospectively collected. Short- and long-term outcomes of two operations were analyzed. The propensity score matching (PSM) was performed to reduce potential selection bias.
RESULTS: A total of 123 patients with sNF-pNETs were enrolled with 62 males, 69 G1, and median age was 56.91 ± 10.04 years old. During the follow-up period (mean 87 ± 58.1 months), 9(7.32%) disease progressed (recurrence or metastasis) and 2 died (1.62%), 5-years OS was 100%, 5-years DFS was 91.4%. Both lymph node metastasis (p = 0.117) and pathological grade (p = 0.050) were not prognostic factors for sNF-pNETs. The propensity score-matched cohort comprised 27 patients with enucleation and 44 patients with regular pancreatectomy. Enucleation was noninferior to regular pancreatectomy in terms of DFS, before or after PSM. The surgical duration (P < 0.01) and blood loss (P < 0.01) significantly decreased in enucleation compared with regular pancreatectomy. The other postoperative complications tended to occur in regular pancreatectomy than in enucleation, but no statistically significant difference (all p > 0.05).
CONCLUSION: Enucleation seems to be an effective option for the treatment of sNF-pNETs with a lower total rate of postoperative complications and similar long-term prognosis, compared with regular pancreatectomy.
Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enucleation; Neuroendocrine tumor; Prognosis; Propensity score-matched analysis; Surgery

Mesh:

Year:  2020        PMID: 31941586     DOI: 10.1016/j.pan.2019.12.007

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  5 in total

1.  Laparoscopic pancreatic enucleation: cystic lesions and proximity to the Wirsung duct increase postoperative pancreatic fistula.

Authors:  Béatrice Aussilhou; Fadhel Samir Ftériche; Morgane Bouquot; Mickael Lesurtel; Alain Sauvanet; Safi Dokmak
Journal:  Surg Endosc       Date:  2022-08-24       Impact factor: 3.453

2.  Enucleation Is a Feasible Procedure for Well-Differentiated pNEN-A Matched Pair Analysis.

Authors:  Anna Nießen; Fabiola A Bechtiger; Ulf Hinz; Magdalena Lewosinska; Franck Billmann; Thilo Hackert; Markus W Büchler; Simon Schimmack
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

3.  Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Juwan Kim; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang
Journal:  World J Gastrointest Oncol       Date:  2020-10-15

4.  Comparison of Outcomes of Enucleation vs. Standard Surgical Resection for Pancreatic Neoplasms: A Systematic Review and Meta-Analysis.

Authors:  Xiaoying Shen; Xiaomao Yang
Journal:  Front Surg       Date:  2022-01-26

5.  Therapeutic experience of a pancreatic mixed serous neuroendocrine neoplasm invading peripancreatic vessels: A case report.

Authors:  Zongming Zhang; Limin Liu; Youwei Li; Zhuo Liu; Chong Zhang; Yue Zhao; Mingwen Zhu; Baijiang Wan; Hai Deng; Xiyuan Xie; Kun Tian; Zhentian Guo; Haiyan Yang; Jiahong Liao; Hongyan Zhu; Lili Liu; Man Wang; Xiaoting Ma; Tiantian Liu; Niuniu Huang; Yujiao Gao; Jing Zhao; Fang Liao; Fengyuan Li; Xueting Wang; Ruijiao Yuan; Xinying Liu; Lidan Chang
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.